News Pharma Industry

Decoding digital health: Can Tata 1mg, PharmEasy, MediBuddy carve a bigger share of the pie?

[ad_1]

Concept by Muhabit ul haq

Synopsis

This story is based on a PrimeTalk conducted by ET Prime on March 10, where industry experts Prashant Tandon of Tata 1mg, Vishal Bali of Asia Healthcare Holdings, and Satish Kannan of MediBuddy shared their views on the rise of digital-healthcare platforms in India, evolving business models, and what’s in store for this sector. Here are the key takeaways.

These days when the doorbell of a house rings, it will mostly be a delivery person standing outside with the package of goods ordered online either from Amazon, Bigbasket, Nykaa, or PharmEasy. Consumer buying patterns have shifted dramatically in recent times. Compared to other sectors, healthcare had been a laggard in digital adoption. But the pandemic has changed it all. The digital-health space in India is buzzing. It is seeing a rise in

  • GIFT ARTICLE
  • FONT SIZE
  • SAVE
  • PRINT
  • COMMENT

Why ?

  • Exclusive Economic Times Stories, Editorials & Expert opinion across 20+ sectors

  • Stock analysis. Market Research. Industry Trends on 4000+ Stocks

  • Clean experience with
    Minimal Ads

  • Comment & Engage with ET Prime community

  • Exclusive invites to Virtual Events with Industry Leaders

  • A trusted team of Journalists & Analysts who can best filter signal from noise

[ad_2]

Source link